6-OHDA mouse model of Parkinson's disease exhibits progressive orexin A neuron loss in lateral hypothalamus
Background
Loss of orexin neurons is a recognized feature in Parkinson's disease (PD) patients, contributing to non-motor symptoms like sleep disturbances, cognitive changes, and gastrointestinal dysfunction. While this neurodegeneration has been observed in post-mortem human brains and rat models, evidence in neurotoxic mouse models of PD has been limited. Understanding this progressive loss in a reproducible mouse model is crucial for investigating the longitudinal mechanisms of PD pathology and developing targeted therapies that might involve orexin A signaling.
Study Design
This pilot study assessed time-dependent orexin neuron loss in a unilateral intrastriatal 6-OHDA mouse model. Mice received a unilateral intrastriatal injection of 6-OHDA to induce a PD-like lesion. Researchers then evaluated orexin A positive neurons in the lateral hypothalamus at 4 weeks and 6-8 weeks post-induction, comparing the lesioned side to the non-lesioned side. An optimized immunohistochemistry protocol for formalin-fixed, paraffin-embedded mouse brain tissue was also established and validated for reliable detection of orexin neurons. Motor deficits, olfactory impairments, cognitive changes, and gastrointestinal dysfunction were also monitored.
Results
A progressive loss of orexin A positive neurons was observed in the lateral hypothalamus on the lesioned side compared to the non-lesioned side. > A significant reduction of orexin A positive neurons in the lateral hypothalamus was evident at 4 weeks post-6-OHDA induction, with further loss observed at 6-8 weeks. This neuronal loss occurred concurrently with a range of PD-like symptoms, including transient motor deficits, olfactory impairments, subtle cognitive changes, and gastrointestinal dysfunction. Furthermore, the study successfully established and validated an orexin A immunohistochemistry protocol for formalin-fixed, paraffin-embedded mouse brain tissue, providing a reproducible and reliable alternative to frozen sections for detecting orexin neurons.
Key Findings
- Progressive loss of orexin A positive neurons observed in the lateral hypothalamus of 6-OHDA lesioned mice.
- Significant reduction of orexin A neurons detected at 4 weeks post-6-OHDA induction.
- Further orexin A neuron loss occurred at 6-8 weeks post-6-OHDA induction.
- Orexin neuron loss correlated with transient motor, olfactory, cognitive, and gastrointestinal deficits.
- Optimized orexin A
immunohistochemistryprotocol established for paraffin-embedded mouse brain tissue.
Why It Matters
This study validates the unilateral intrastriatal 6-OHDA mouse model as a suitable tool for recapitulating progressive orexin A neuron loss seen in human Parkinson's disease. This is a significant step for researchers, enabling more robust longitudinal studies into the mechanisms underlying PD symptoms, particularly those related to orexin system dysfunction. The established immunohistochemistry protocol is a practical advancement, offering a more accessible and reproducible method for assessing orexin neuron integrity, which could accelerate preclinical drug discovery efforts for orexin-modulating compounds in PD.
parkinsons-disease
neurodegeneration
orexin-a
mouse-model
immunohistochemistry
preclinical-animal